|
External
Counter Pulsation (ECP), also referred to as
Enhanced External Counter Pulsation (EECP), is a
noninvasive treatment for angina and blocked arteries in
the heart. Since no surgery is needed you do not have to
be admitted to the hospital; you are not cut and no
devices are inserted into you. The treatment is very
safe with no serious side effects reported in tens of
thousands patients who have been studied worldwide. The
technique is based on pumping blood from the legs and
sometimes arms back into the heart when the heart is in
its resting phase known as diastole, resulting in
increased blood flow to heart muscle and heart chambers,
and therefore to all other organs in the body. The
increased blood flowing through the vessel can also
result in the production of new blood vessels in the
heart muscle, called collateral circulation. The
increase in the amount of good vessels to carry the
blood increases the oxygen available to the heart.
Decreased oxygen in the heart muscle causes the angina
and increasing the oxygen decreases or eliminates the
angina. The reduction in the heart pain (angina) is one
example of the heart working better. The other effects
are increased energy, increased ability to do day to day
activities, such as walking, climbing stairs, working
and sexual intercourse. Since the heart is functioning
better, the patient frequently takes less heart
medication. ECP is effective for patients with blocked
arteries in their heart and angina, and ECP treatment of
angina is covered by Medicare and many private insurance
carriers. It has also been approved for the treatment of
patients with congestive heart failure (CHF). The
application for Medicare reimbursement for CHF is still
under review. Patients generally not eligible for
treatment are:
- Those with atrial fibrillation or other
serious arrhythmias
- Use of Coumadin or another anticoagulant
- Bleeding diathesis
- Aortic valve insufficiency
- Active thrombophlebitis
- Severe lower extremity vaso-occlusive
disease
- Recent cardiac catheterization
- Aortic aneurysm requiring surgical repair
- Uncontrolled severe high blood pressure or
rapid heart rate
- Pregnancy
|
The latest
AngioNew ECP systems from life enhancement technology LTD.
incorporate technologies and know-how gained from the
development and production of ECP devices for over 20
years, and represent the state of the art of sequential
external counterpulsation. They are approved by the US
FDA for treating angina pectoris, acute myocardial
infarction, cardiogenic shock and congestive heart
failure (CHF). They are also CE Mark certified for
marketing in all EU countries.
| LETL
. is committed to the enhancement of health
and improvement of quality of life by bringing
innovative and safe treatments for diseases
related to
ischemia. | 
|
